Uploaded November 2025 | Updated September 2026, 2 weeks ago
Dr. Howie Rosen from the Fein Memory and Aging Center discusses the latest developments in frontotemporal dementia (FTD) research. Key points include:
• FTD is a neurodegenerative disease that affects younger patients and presents with different symptoms than Alzheimer's disease. There has been a significant increase in research on FTD in the past 1.5 years.
• Researchers are exploring various therapeutic approaches for FTD, including small molecules, antibodies, gene therapy, and brain stimulation. Diagnostic tools like blood tests and MRI are being developed to detect FTD early and differentiate it from psychiatric disorders.
• Large collaborative studies are tracking the progression of FTD, especially in patients with genetic mutations, to better understand the disease biology and develop effective monitoring methods. These collaborative efforts are accelerating discoveries in this less common form of dementia.
Dr. Howie Rosen from the Fein Memory and Aging Center discusses the latest developments in frontotemporal dementia (FTD) research. Key points include:
• FTD is a neurodegenerative disease that affects younger patients and presents with different symptoms than Alzheimer's disease. There has been a significant increase in research on FTD in the past 1.5 years.
• Researchers are exploring various therapeutic approaches for FTD, including small molecules, antibodies, gene therapy, and brain stimulation. Diagnostic tools like blood tests and MRI are being developed to detect FTD early and differentiate it from psychiatric disorders.
• Large collaborative studies are tracking the progression of FTD, especially in patients with genetic mutations, to better understand the disease biology and develop effective monitoring methods. These collaborative efforts are accelerating discoveries in this less common form of dementia.
